Magnolia Medical Technologies logo

Magnolia Medical Technologies

Partnering with you to achieve near-zero blood culture contamination rates with Steripath

106 employees · est. 2006 · Seattle, United States

VS
T2 Biosystems logo

T2 Biosystems

Rapid detection of sepsis-causing pathogens

140 employees · est. 2006 · Lexington, United States

Side-by-Side Comparison

Magnolia Medical Technologies T2 Biosystems
Founded
2006 2006
Headquarters
Seattle, United States Lexington, United States
Employees
106 140
Industry
Health Care, Medical Devices Biotechnology, Health Care
Funding Stage
Private Equity Post Ipo Equity
Total Funding
$117.33M $316.63M
Funding Rounds
9 14
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Medical Device, Diagnostic Testing, Patient Safety, Sepsis Prevention, Infectious Disease Prevention, Blood Culture Collection, Antimicrobial Stewardship, Medical Reimbursement, Intellectual Property, Clinical Practice Improvement, Seattle, Innovation, Evidence-based Technology Medical Diagnostics, In Vitro Diagnostics, Sepsis, Hemostasis, Bacteria, Lyme Disease, Pathogen Detection, T2MR® Technology, Nanotechnology, Magnetic Resonance Technology, Rapid Diagnostics, FDA-cleared Products, Medical Innovation, Health Technology
Website
magnolia-medical.com t2biosystems.com
Magnolia Medical Technologies logo

About Magnolia Medical Technologies

Magnolia Medical Technologies is a Health Care startup founded in 2011 and headquartered in the United States. The company's mission revolves around their innovative product, Steripath, aiming to achieve near-zero blood culture contamination rates. Their technology addresses the problem of contamina...

T2 Biosystems logo

About T2 Biosystems

T2 Biosystems is dedicated to the rapid detection of sepsis-causing pathogens. The company, established in 2006 and headquartered in the United States, focuses on developing innovative diagnostic products to improve patient health, particularly targeting sepsis, hemostasis, bacteria, and Lyme diseas...

We will tell you when either one moves

BounceWatch watches Magnolia Medical Technologies and T2 Biosystems for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Magnolia Medical Techn... and T2 Biosystems — by email.

Frequently Asked Questions

Magnolia Medical Technologies — Partnering with you to achieve near-zero blood culture contamination rates with Steripath. T2 Biosystems — Rapid detection of sepsis-causing pathogens. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Magnolia Medical Technologies has raised $117.33M while T2 Biosystems has raised $316.63M.
Magnolia Medical Technologies and T2 Biosystems operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Magnolia Medical Technologies with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Magnolia Medical Technologies on 12 Sep 2024, and T2 Biosystems on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes